EUVIMEDEUVIMED entdecken
Crossref

Hepatitis B in transition in Mauritania: HBsAg seroprevalence in patients attending the Cheikh Zayed National Hospital, Nouakchott (2019–2020)

Hala El Hachimi, Cheikh Yebouk, Fatimetou Khiddi, Mohamed Mahmoud El Alem, Mohamed Vall Mohamed Abdellahi

Annales Pharmaceutiques Françaises · 2026

DOI: 10.1016/j.pharma.2026.02.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annales Pharmaceutiques Françaises, 2026. Verfasst von Hala El Hachimi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Epidemiology and Diversity of Microorganisms, Faculty of Sciences and Techniques Nouakchott-University, Nouakchott, Mauritania; Department of…. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens, Hepatitis B. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Over a million people die each year from hepatitis B virus (HBV) infections, which are a serious global public health problem. More than seventy percent of adults in highly endemic areas, mainly in Africa and Southeast Asia, have signs of prior infection, and 7-20% of individuals are chronically infected. In Mauritania, hepatitis B is endemic, with infection rates ranging from 10 to 20%. METHODS: A descriptive cross-sectional study was conducted between January 2019 and May 2020. Participants were recruited at Cheikh Zayed Hospital in Nouakchott. All patients presenting to the Cheikh Zaid Hospital laboratory for medical tests were recruited. Patients were referred by physicians from various hospital departments and provided informed consent prior to serological testing (HBsAg) for the detection of the hepatitis B virus surface antigen. RESULTS: During the research period, from 1st January 2019 to 30th May 2020, 10,735 people were examined, and 1223 people (472 men and 751 women) were determined to be HBsAg positive, resulting in an overall seroprevalence of 11.4 percent. It is greater in males (12.9%) than in women (10.6%). CONCLUSION: Following the introduction of hepatitis B vaccination and the strengthening of viral hepatitis control activities, a decrease in HBsAg seroprevalence was observed in this hospital population; however, this trend is probably multifactorial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B Surface AntigensHepatitis BHumansMauritaniaFemaleMaleSeroepidemiologic StudiesCross-Sectional StudiesAdultMiddle AgedYoung AdultAdolescentAged

Stichwörter der Autor:innen

HBsAgHepatitis BHépatite BMauritaniaMauritanieNouakchottPrévalenceSeroprevalence

Substanzen

Hepatitis B Surface Antigens

Autor:innen und Institutionen

  • Unit of Epidemiology and Diversity of Microorganisms, Faculty of Sciences and Techniques Nouakchott-University, Nouakchott, Mauritania; Department of Virology, National Institute of Public Health Research (INRSP), Nouak…
  • Laboratoire national de contrôle de la qualité des médicaments, Nouakchott, Mauritania. Electronic address: yebouk55@gmail.com.
  • Unit of Epidemiology and Diversity of Microorganisms, Faculty of Sciences and Techniques Nouakchott-University, Nouakchott, Mauritania.

Zitieren

APA

El Hachimi, H., Yebouk, C., Khiddi, F., El Alem, M. M., & Abdellahi, M. V. M. (2026). Hepatitis B in transition in Mauritania: HBsAg seroprevalence in patients attending the Cheikh Zayed National Hospital, Nouakchott (2019–2020). Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2026.02.006

Vancouver

El Hachimi H, Yebouk C, Khiddi F, El Alem MM, Abdellahi MVM. Hepatitis B in transition in Mauritania: HBsAg seroprevalence in patients attending the Cheikh Zayed National Hospital, Nouakchott (2019–2020). Annales Pharmaceutiques Françaises. 2026. doi:10.1016/j.pharma.2026.02.006

BibTeX
@article{ElHachimi2026,
  author = {El Hachimi, Hala and Yebouk, Cheikh and Khiddi, Fatimetou and El Alem, Mohamed Mahmoud and Abdellahi, Mohamed Vall Mohamed},
  title = {Hepatitis B in transition in Mauritania: HBsAg seroprevalence in patients attending the Cheikh Zayed National Hospital, Nouakchott (2019–2020)},
  journal = {Annales Pharmaceutiques Françaises},
  year = {2026},
  doi = {10.1016/j.pharma.2026.02.006}
}
Kostenlos starten →